We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Henry Schein (HSIC) Stock Moves -0.17%: What You Should Know
Read MoreHide Full Article
Henry Schein (HSIC - Free Report) closed at $82.43 in the latest trading session, marking a -0.17% move from the prior day. This move was narrower than the S&P 500's daily loss of 0.21%. Meanwhile, the Dow lost 0.42%, and the Nasdaq, a tech-heavy index, lost 0.64%.
Heading into today, shares of the health care products maker had gained 5.66% over the past month, lagging the Medical sector's gain of 7.66% and the S&P 500's gain of 7.71% in that time.
Investors will be hoping for strength from Henry Schein as it approaches its next earnings release. On that day, Henry Schein is projected to report earnings of $1.24 per share, which would represent a year-over-year decline of 4.62%. Meanwhile, our latest consensus estimate is calling for revenue of $3.11 billion, down 2.03% from the prior-year quarter.
HSIC's full-year Zacks Consensus Estimates are calling for earnings of $5.32 per share and revenue of $12.84 billion. These results would represent year-over-year changes of +10.6% and +1.53%, respectively.
It is also important to note the recent changes to analyst estimates for Henry Schein. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Henry Schein is currently sporting a Zacks Rank of #1 (Strong Buy).
In terms of valuation, Henry Schein is currently trading at a Forward P/E ratio of 15.51. This valuation marks a discount compared to its industry's average Forward P/E of 21.52.
Investors should also note that HSIC has a PEG ratio of 1.91 right now. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. HSIC's industry had an average PEG ratio of 2.19 as of yesterday's close.
The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 45, putting it in the top 18% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Henry Schein (HSIC) Stock Moves -0.17%: What You Should Know
Henry Schein (HSIC - Free Report) closed at $82.43 in the latest trading session, marking a -0.17% move from the prior day. This move was narrower than the S&P 500's daily loss of 0.21%. Meanwhile, the Dow lost 0.42%, and the Nasdaq, a tech-heavy index, lost 0.64%.
Heading into today, shares of the health care products maker had gained 5.66% over the past month, lagging the Medical sector's gain of 7.66% and the S&P 500's gain of 7.71% in that time.
Investors will be hoping for strength from Henry Schein as it approaches its next earnings release. On that day, Henry Schein is projected to report earnings of $1.24 per share, which would represent a year-over-year decline of 4.62%. Meanwhile, our latest consensus estimate is calling for revenue of $3.11 billion, down 2.03% from the prior-year quarter.
HSIC's full-year Zacks Consensus Estimates are calling for earnings of $5.32 per share and revenue of $12.84 billion. These results would represent year-over-year changes of +10.6% and +1.53%, respectively.
It is also important to note the recent changes to analyst estimates for Henry Schein. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Henry Schein is currently sporting a Zacks Rank of #1 (Strong Buy).
In terms of valuation, Henry Schein is currently trading at a Forward P/E ratio of 15.51. This valuation marks a discount compared to its industry's average Forward P/E of 21.52.
Investors should also note that HSIC has a PEG ratio of 1.91 right now. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. HSIC's industry had an average PEG ratio of 2.19 as of yesterday's close.
The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 45, putting it in the top 18% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.